NASDAQ$ALHC

Alignment Healthcare Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Alignment Healthcare reported strong financial results for Q4 2022, exceeding or meeting guidance across all key performance indicators.

Alignment Healthcare reported financial results for the fourth quarter and full year ending Dec. 31, 2022. The company exceeded or met its guidance across all four of its key performance indicators for the eighth consecutive quarter.

  • Alignment Healthcare delivered strong financial results in 2022.
  • The company exceeded or met its guidance across all four of its key performance indicators for the eighth consecutive quarter.
  • Strategic investments in people and technology will continue to drive meaningful improvements.
  • Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives.

Headline financials

Total Revenue

$362M

Previous: $298M+21.3%
EPS (adj)

-$0.31

Previous: -$0.27-14.8%
Net Income

-$57M

Previous: -$47.8M-19.2%
Operating Income

-$52.1M

Previous: -$43.5M-19.9%
Gross Profit

$35.8M

Previous: $38.7M-7.5%
Cash & Equivalents

$410M

Previous: $467M-12.2%
Total Assets

$634M

Previous: $631M+0.5%
Stock-Based Comp

-$58.8M

Previous: $621K-9573.9%

Revenue & EPS history

Alignment Healthcare · Revenue · Quarterly

$362M

Q4 2022+21.3%vs Q4 2021
Beat estimate in 15 of 15 quarters(100%)
ActualEstimate

Revenue by segment

Alignment Healthcare · $265M total across 2 segments · Q1 2021

  • Earned premiums
    $265M+18.0%
  • Other revenue
    $82K

Forward guidance

The release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and our financial outlook for the first quarter ending March 31, 2023, and year ending December 31, 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+1.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+2.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+27.0%

Q1 2024

Best reaction

-16.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-15.7%-29.5%
Q4 2025-5.8%-7.5%-18.6%
Q3 2025-1.9%-0.4%+12.2%
Q1 2025-7.7%-7.5%-8.3%
Q4 2024+16.5%+17.4%+35.9%
Q3 2024+1.6%+12.2%+11.2%
Q2 2024+2.3%+4.9%+3.1%
Q1 2024+27.0%+31.6%+51.0%
Q4 2023-8.9%-9.2%-20.1%
Q3 2023-9.6%-7.2%+10.5%
Q2 2023+7.5%+10.5%-4.2%
Q1 2023+3.5%+11.3%-5.1%
Q4 2022-16.4%-20.9%-35.2%
Q3 2022-3.1%-3.3%-2.7%
Q2 2022+10.4%+4.3%-8.7%
Q1 2022-7.0%-18.8%+6.8%
Q4 2021+10.7%+8.0%+39.7%
Q3 2021+10.6%+6.1%-26.7%
Q2 2021-8.5%-4.8%-11.2%
Q1 2021+6.8%+13.3%+27.6%
Q4 2020+6.8%+13.3%+27.6%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro